Castle Biosciences Inc (CSTL)

Cost of Revenue

$23.70M

Quarterly · Period ending: · USD

CSTL logo

CSTL Cost of Revenue

Latest reported$23.70M
CSTL Quarterly Cost of Revenue ($1.25M → $23.70M)
High-resolution chart · PNG

CSTL cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Castle Biosciences Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
23,700,000
20,533,000
18,315,000
18,704,000
17,626,000
16,383,000
16,183,000
15,609,000
14,519,000
13,894,000
12,423,000
11,319,000
11,058,000
10,182,000
9,520,000
8,859,000
7,686,000
5,944,000
4,597,000
4,500,000
3,697,000
3,028,000
2,673,000
2,475,000
2,146,000
2,391,000
2,010,536
1,708,722
1,992,784
1,597,958
1,366,228
1,350,799
1,326,839
1,252,983
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.